Jer-Tsong Hsieh

Jer-Tsong Hsieh is a prominent inventor based in Plano, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic agents. With a total of 3 patents, Hsieh is recognized for his work in creating effective solutions for combating various types of cancer.

Latest Patents

Hsieh's latest patents include groundbreaking inventions such as histone demethylase inhibitors for treating cancers. This patent discloses a new series of 8-hydroxyquinoline derivatives that serve as potent KDM4 inhibitors, demonstrating high activity and selectivity against KDM4 enzymes. Additionally, the patent outlines pharmaceutical compositions that incorporate these inhibitors, providing methods for treating cancer and neoplastic diseases.

Another notable patent focuses on imaging and therapeutic targeting of prostate and bladder tissues. This invention presents methods for imaging and treating cancer, utilizing polyarginine to selectively image prostate or bladder cells. Furthermore, it describes the use of a DOC-2/DAB2 peptide, which can be conjugated to a cell-permeable peptide for treating cancers such as prostate cancer.

Career Highlights

Jer-Tsong Hsieh is affiliated with the University of Texas System, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential impact on improving treatment outcomes for patients suffering from various cancers.

Collaborations

Hsieh has collaborated with notable colleagues, including Leland W Chung and James Chan, to further enhance the scope and effectiveness of his research. These collaborations have contributed to the development of innovative solutions in the field of oncology.

Conclusion

Jer-Tsong Hsieh is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic options. His innovative patents reflect a commitment to improving patient care and advancing medical science.